Large-scale testing (Phase 3)Active Not RecruitingNCT04616326
What this trial is testing
Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
Who this might be right for
Chronic Migraine
Eli Lilly and Company 312
Showing 20 of 68 results